We employed two independent approaches to inactivate the angiogenic protein VEGF in newborn mice: inducible, Cre-loxP- mediated gene targeting, or administration of mFlt(1–3)-IgG, a soluble VEGF receptor chimeric protein. Partial inhibition of VEGF achieved by inducible gene targeting resulted in increased mortality, stunted body growth and impaired organ development, most notably of the liver. Administration of mFlt(1–3)-IgG, which achieves a higher degree of VEGF inhibition, resulted in nearly complete growth arrest and lethality. Ultrastructural analysis documented alterations in endothelial and other cell types. Histological and biochemical changes consistent with liver and renal failure were observed. Endothelial cells isolated from the liver of mFlt(1–3)-IgG-treated neonates demonstrated an increased apoptotic index, indicating that VEGF is required not only for proliferation but also for survival of endothelial cells. However, such treatment resulted in less significant alterations as the animal matured, and the dependence on VEGF was eventually lost some time after the fourth postnatal week. Administration of mFlt(1–3)-IgG to juvenile mice failed to induce apoptosis in liver endothelial cells. Thus, VEGF is essential for growth and survival in early postnatal life. However, in the fully developed animal, VEGF is likely to be involved primarily in active angiogenesis processes such as corpus luteum development.

Reference

Alon
T.
,
Hemo
I.
,
Itin
A.
,
Pe'er
J.
,
Stone
J.
,
Keshet
E.
(
1995
)
Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity.
Nat. Med
1
,
1024
028
Augustin
H. G.
,
Braun
K.
,
Telemenakis
I.
,
Modlich
U.
,
Kuhn
W.
(
1995
)
Ovarian angiogenesis. Phenotypic characterization of endothelial cells in a physiological model of blood vessel growth and regression.
Am. J. Pathol
147
,
339
351
Baker
J.
,
Liu
J. P.
,
Robertson
E. J.
,
Efstratiadis
A.
(
1993
)
Role of insulin-like growth factors in embryonic and postnatal growth.
Cell
75
,
73
82
Benjamin
L.
,
Hemo
I.
,
Keshet
E.
(
1998
)
A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF.
Development
125
,
1591
1598
Benjamin
L. E.
,
Keshet
E.
(
1997
)
Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal.
Proc. Natl. Acad. Sci. USA
94
,
8761
8766
Borgström
P.
,
Bourdon
M. A.
,
Hillan
K. J.
,
Sriramarao
P.
,
Ferrara
N.
(
1998
)
Neutralizing anti-vascular endothelial growth factor antibody completely inhibits angiogenesis and growth of human prostate carcinoma micro tumors in vivo.
Prostate
35
,
1
10
Brooks
P. C.
,
Montgomery
A. M.
,
Rosenfeld
M.
,
Reisfeld
R. A.
,
Hu
T.
,
Klier
G.
,
Cheresh
D. A.
(
1994
)
Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels.
Cell
79
,
1157
1164
Broxmwyer
H. E.
,
Cooper
S.
,
Li
Z. H.
,
Song
H. Y.
,
Kwon
B. S.
,
Warren
R. E.
,
Donner
D. B.
(
1995
)
Myeloid progenitor cell regulatory effects of vascular endothelial growth factor.
Int. J. Hematol
62
,
203
215
Carmeliet
P.
,
Collen
D.
(
1998
)
Vascular development and disorders: Molecular analysis and pathogenic insights.
Kidney Internat
53
,
1519
1549
Carmeliet
P.
,
Ferreira
V.
,
Breier
G.
,
Pollefeyt
S.
,
Kieckens
L.
,
Gertsenstein
M.
,
Fahrig
M.
,
Vandenhoeck
A.
,
Harpal
K.
,
Eberhardt
C.
,
Declercq
C.
,
Pawling
J.
,
Moons
L.
,
Collen
D.
,
Risau
W.
,
Nagy
A.
(
1996
)
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele.
Nature
380
,
435
439
Clapp
C.
,
Martial
J. A.
,
Guzman
R. C.
,
Rentier-Delrue
F.
,
Weiner
R. I.
(
1993
)
The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis.
Endocrinology
133
,
1292
1299
Davis-Smyth
T.
,
Chen
H.
,
Park
J.
,
Presta
L. G.
,
Ferrara
N.
(
1996
)
The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade.
EMBO J
15
,
4919
4927
Esser
S.
,
Wolburg
K.
,
Wolburg
H.
,
Breier
G.
,
Kurzchalia
T.
,
Risau
W.
(
1998
)
Vascular endothelial growth factor induces endothelial fenestrations in vitro.
J. Cell Biol
140
,
947
959
Ferrara
N.
,
Carver Moore
K.
,
Chen
H.
,
Dowd
M.
,
Lu
L.
,
O'Shea
K. S.
,
Powell Braxton
L.
,
Hillan
K. J.
,
Moore
M. W.
(
1996
)
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene.
Nature
380
,
439
442
Ferrara
N.
,
Chen
H.
,
Davis-Smyth
T.
,
Gerber
H.-P.
,
Nguyen
T.-N.
,
Peers
D.
,
Chisholm
V.
,
Hillan
K. J.
,
Schwall
R. H.
(
1998
)
Vascular endothelial growth factor is essential for corpus luteum angiogenesis.
Nat. Med
4
,
336
340
Ferrara
N.
,
Davis-Smyth
T.
(
1997
)
The biology of vascular endothelial growth factor.
Endocr. Rev
18
,
4
25
Fong
G. H.
,
Rossant
J.
,
Gertsenstein
M.
,
Breitman
M. L.
(
1995
)
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium.
Nature
376
,
66
70
Gerber
H. P.
,
Dixit
V.
,
Ferrara
N.
(
1998
)
Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells.
J. Biol. Chem
273
,
13313
13316
Gerber
H. P.
,
McMurtrey
A.
,
Kowalski
J.
,
Yan
M.
,
Keyt
B.
,
Dixit
V.
,
Ferrara
N.
(
1998
)
VEGF regulates endothelial cell survival by the PI3-kinase/Akt Signal transduction pathway. Requirement for Flk-1/KDR activation.
J. Biol. Chem
273
,
30336
30345
Gibson
U. E. M.
,
Heid
C. A.
,
Williams
P. M.
(
1996
)
A novel method for real time quantitative RT-PCR.
Genome Res
6
,
995
1001
Good
D.
,
Polverini
P.
,
Rastinejad
F.
,
Beau
M.
,
Lemons
R.
,
Frazier
W.
,
Bouck
N.
(
1990
)
A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin.
Proc. Natl. Acad. Sci. USA
87
,
6624
6628
Gu
H.
,
Marth
J. D.
,
Orban
P. C.
,
Mossmann
H.
,
Rajewsky
K.
(
1994
)
Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting.
Science
265
,
103
106
Heid
C. A.
,
Stevens
J.
,
Livak
K. J.
,
Williams
P. M.
(
1996
)
Real time quantitative PCR.
Genome Res
6
,
986
994
Hiratsuka
S.
,
Minowa
O.
,
Kuno
J.
,
Noda
T.
,
Shibuya
M.
(
1998
)
Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice.
Proc. Natl. Acad. Sci. USA
95
,
9349
9354
Hirschi
K. K.
,
D'Amore
P. A.
(
1996
)
Pericytes in the microvasculature.
Cardiovasc. Res
32
,
687
698
Huang
S.
,
Hendriks
W.
,
Althage
A.
,
Hemmi
S.
,
Bluethmann
H.
,
Kamijo
R.
,
Vilcek
J.
,
Zinkernagel
R. M.
,
Aguet
M.
(
1993
)
Immune response in mice that lack the interferon-gamma receptor.
Science
259
,
1742
1745
Jelkmann
W.
(
1992
)
Erythropoietin: structure, control of production and function.
Physiol. Rev
72
,
449
489
Katoh
O.
,
Tauchi
H.
,
Kawaishi
K.
,
Kimura
A.
,
Sarow
Y.
(
1995
)
Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopietic cells and inhibitory effects of VEGF on apoptotic cell death caused by ionizing radiations.
Cancer Res
55
,
5687
5692
Keyt
B. A.
,
Nguyen
H. V.
,
Berleau
L. T.
,
Duarte
C. M.
,
Park
J.
,
Chen
H.
,
Ferrara
N.
(
1996
)
Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis.
J. Biol. Chem
271
,
5638
5646
Kitamoto
Y.
,
Tokunaga
H.
,
Tomita
K.
(
1997
)
Vascular endothelial growth factor is an essential molecule for mouse kidney development.
J. Clin. Invest
99
,
2351
2357
Kuhn
R.
,
Schwenk
F.
,
Aguet
M.
,
Rajewsky
K.
(
1995
)
Inducible gene targeting in mice.
Science
269
,
1427
1429
Monacci
W. T.
,
Merrill
M. J.
,
Oldfield
E. H.
(
1993
)
Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues.
Am. J. Physiol
264
,
995
1002
Nehls
V.
,
Drenckhahn
D.
(
1993
)
The versatility of microvascular pericytes: From mesenchyme to smooth muscle?.
Histochemistry
99
,
1
12
O'Reilly
M. O.
,
Boehm
T.
,
Shing
Y.
,
Fukai
N.
,
Vasios
G.
,
Lane
W. S.
,
Flynn
E.
,
Birkhead
J. R.
,
Olsen
B. R.
,
Folkman
J.
(
1997
)
Endostatin: An endogenous inhibitor of angiogenesis and tumor growth.
Cell
88
,
277
285
O'Reilly
M. S.
,
Holmgren
L.
,
Shing
Y.
,
Chen
C.
,
Rosenthal
R. A.
,
Moses
M.
,
Lane
W. S.
,
Cao
Y.
,
Sage
E. H.
,
Folkman
J.
(
1994
)
Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma.
Cell
79
,
315
328
Patan
S.
,
Haenni
B.
,
Burri
P. H.
(
1997
)
Implementation of intussusceptive microvascular growth in the chicken chorioallantoic membrane (CAM).
Microvasc. Res
53
,
33
52
Presta
L. G.
,
Chen
H.
,
O'Connor
S. J.
,
Chisholm
V.
,
Meng
Y. G.
,
Krummen
L.
,
Winkler
M.
,
Ferrara
N.
(
1997
)
Humanization of an anti-VEGF monoclonal antibody for the therapy of solid tumors and other disorders.
Cancer Res
57
,
4593
4599
Quinn
T. P.
,
Peters
K. G.
,
De Vries
C.
,
Ferrara
N.
,
Williams
L. T.
(
1993
)
Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium.
Proc. Natl. Acad. Sci. USA
90
,
7533
7637
Risau
W.
(
1995
)
Differentiation of endothelium.
FASEB J
9
,
926
933
Risau
W.
(
1997
)
Mechanisms of angiogenesis.
Nature
386
,
671
674
Roberts
W. G.
,
Palade
G. E.
(
1995
)
Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor.
J. Cell Sci
108
,
2369
2379
Sage
E. H.
,
Bassuk
J. A.
,
Vost
J. C.
,
Folkman
M. J.
,
Lane
T. F.
(
1995
)
Inhibition of endothelial cell proliferation by SPARC is mediatedthrough a Ca (2+)-binding EF-hand sequence.
J. Cell Biochem
57
,
127
140
Shalaby
F.
,
Rossant
J.
,
Yamaguchi
T. P.
,
Gertsenstein
M.
,
Wu
X. F.
,
Breitman
M. L.
,
Schuh
A. C.
(
1995
)
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice.
Nature
376
,
62
66
Shalaby
F.
,
Ho
J.
,
Stanford
W. L.
,
Fisher
K. D.
,
Schuh
A. C.
,
Schwartz
L.
,
Bernstein
A.
,
Rossant
J.
(
1997
)
A requirement for flk-1 in primitive and definitive hematopoiesis.
Cell
89
,
981
990
Vecchi
A.
,
Garlanda
C.
,
Lampugnani
M. G.
,
Resnati
C.
,
Matteucci
C.
,
Stoppacciaro
A.
,
Schnurch
H.
,
Risau
W.
,
Ruco
L.
,
Mantovani
A.
,
Dejana
E.
(
1994
)
Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embryonic endothelium.
Eur. J. Cell Biol
63
,
247
254
Yuan
F.
,
Chen
Y.
,
Dellian
M.
,
Safabakhsh
N.
,
Ferrara
N.
,
Jain
R. K.
(
1996
)
Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody.
Proc. Natl. Acad. Sci. USA
93
,
14765
14770
This content is only available via PDF.